Quantcast
Last updated on April 20, 2014 at 21:20 EDT

Latest Regenerative medicine Stories

2014-01-07 08:30:25

ST. LOUIS, Jan. 7, 2014 /PRNewswire/ -- ISTO Technologies, Inc., a privately-held orthobiological regenerative medicine company, announced today that James McGorry, a seasoned executive with deep healthcare industry experience, has been appointed to its Board of Directors. "We welcome Jim McGorry, whose expertise in the biotech industry and leadership experience with ground-breaking oncological and transplant therapies will help guide ISTO as we continue to develop and promote our...

2014-01-06 08:24:58

58% Year over Year Growth Driven by Increased Adoption of Proprietary Products and Contract Manufacturing Services BOTHELL, Wash., Jan. 6, 2014 /PRNewswire/ -- BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical-grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues, today announced preliminary revenue of $9.0 million for the full year 2013. This represents...

2013-12-30 23:04:26

Navy Corpsman Joins 29 Organ and Tissue Transplant Recipients as Float Riders to Demonstrate Appreciation of Life-Saving Donor Gifts Alachua, FL (PRWEB) December 30, 2013 AxoGen, Inc. (NASDAQ: AXGN), a leading regenerative medicine company focused on the development and commercialization of products and technologies for peripheral nerve reconstruction and regeneration, today announced that Navy Corpsman Edward Bonfiglio, a patient who received limb sparing surgery utilizing AxoGen’s...

2013-12-30 08:25:24

MONT-SAINT-GUIBERT, Belgium, December 30, 2013 /PRNewswire/ -- Cardio3 BioSciences (C3BS) (NYSE Euronext Brussels and Paris: CARD), a leader in the discovery and development of regenerative, protective and reconstructive therapies for the treatment of cardiac diseases, announces its participation in the forthcoming Annual JP Morgan Healthcare Conference in San Francisco, on January 13 to 16, 2014. By participating at the industry's largest and most informative...

2013-12-19 23:03:00

A4M’s 21st Annual World Congress on Anti-Aging, Regenerative and Aesthetic Medicine was held at the Sands Expo Center at the Venetian/ Palazzo Resort in Las Vegas and welcomed thousands of medical practitioners and exhibitors. Boca Raton, FL (PRWEB) December 19, 2013 A4M’s largest event, the 21st Annual World Congress on Anti-Aging, Regenerative and Aesthetic Medicine wrapped up on Sunday, December 15th with a record number of attendees and exhibitors present. Over 3,500 attendees,...

2013-12-19 08:28:04

SAN DIEGO, Dec. 19, 2013 /PRNewswire/ -- ViaCyte, Inc., a leading regenerative medicine company developing a transformative cell therapy for treatment of diabetes, announced today that Mark G. Foletta has been appointed to its Board of Directors. (Logo: http://photos.prnewswire.com/prnh/20121026/LA00871LOGO-a) Mr. Foletta is a seasoned financial executive with over 30 years of corporate experience. He was most recently senior vice president and Chief Financial Officer at Amylin...

2013-12-17 11:33:06

Mayo Clinic researchers and colleagues in Belgium have developed a specialized catheter for transplanting stem cells into the beating heart. The novel device includes a curved needle and graded openings along the needle shaft, allowing for increased distribution of cells. The result is maximized retention of stem cells to repair the heart. The findings appear in the journal Circulation: Cardiovascular Interventions. "Although biotherapies are increasingly more sophisticated, the tools for...

2013-12-16 08:27:05

WASHINGTON, Dec. 16, 2013 /PRNewswire-USNewswire/ -- Cord Blood Registry (CBR) and Viacord, a division of PerkinElmer Inc. - two of the largest family cord blood banks in the nation - joined together today to praise U.S. Representatives Aaron Schock (R-IL) and Ron Kind (D-WI) for reintroducing HR 3673, the Family Cord Blood Banking Act. (Logo: http://photos.prnewswire.com/prnh/20131216/DC33657LOGO-a)(Logo: http://photos.prnewswire.com/prnh/20131216/DC33657LOGO-b) The bipartisan...

Researchers Help Develop A Dynamic Model Of Tissue Failure
2013-12-12 17:45:57

University of Pennsylvania The idea of growing replacement tissue to repair an organ, or to swap it out for an entirely new one, is rapidly transitioning from science fiction to fact. Tissue engineering techniques are improving in their ability to generate three-dimensional masses of cells and provide them with vascular systems for keeping them alive, but a more mathematically rigorous approach for designing these tissues is still needed. Researchers at the University of Pennsylvania,...

2013-12-11 12:25:22

MONT-SAINT-GUIBERT, Belgium, December 11, 2013 /PRNewswire/ -- Study Demonstrates Enhanced Endomyocardial Therapeutics Retention through an Optimized Delivery System Cardio3 BioSciences (C3BS) (NYSE Euronext Brussels and Paris: CARD), a leader in the discovery and development of regenerative, protective and reconstructive therapies for the treatment of cardiac diseases, today announces the advanced publication of C-Cath(R)...